Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSigmaroc. Regulatory News (SRC)

Share Price Information for Sigmaroc. (SRC)

Share Price is delayed by 15 minutes
Get Live Data
124.80    5.50 (4.61%)
Bid:
124.10
Ask:
124.80
Spread: 0.70 (0.564%)
Market Cap: £1.38b
SRC Live PriceLast checked at - London Stock Exchange

Intraday Sigmaroc. Share Chart

Company Update

3 May 2017 07:00

RNS Number : 9749D
SigmaRoc PLC
03 May 2017
 

3 May 2017

 

SigmaRoc plc

 

('SigmaRoc' or the 'Company')

 

Update on Debt Facilities, Appointment of Joint Broker and Option Exercise

 

SigmaRoc plc, the AIM listed construction materials business (AIM: SRC), wishes to update the market on the following items:

 

Santander Debt Facilities

 

SigmaRoc confirms that it has satisfied the conditions in relation to the Santander UK plc ('Santander') debt facilities announced on 21 February 2017. Accordingly, the Company has now signed the £2 million Revolving Credit Facility agreement.

 

The terms and conditions for the £18 million term facility (the 'Term Facility') with Santander have also been agreed. It is envisaged that the Term Facility agreement will be finalised and executed in due course as SigmaRoc pursues its expansion pipeline.

 

Joint Broker to the Company

 

SigmaRoc is pleased to announce the appointment of Berenberg as a Joint Broker to the Company, alongside Zeus Capital Limited, with immediate effect.

 

Option Exercise and Total Voting Rights

 

Additionally, SigmaRoc announces that it has received notification from an option holder to exercise options over 104,059 new ordinary shares of 1 pence each in the capital of the Company (the 'New Ordinary Shares'), at an exercise price of 25 pence per share raising, in aggregate, £26,014.75.

 

Application will be made for the New Ordinary Shares to be admitted to trading on the AIM market of the London Stock Exchange ('Admission'). Admission is expected to occur on or around 8 May 2017.

Following the issue of the New Ordinary Shares, the total issued share capital of the Company consists of 102,705,557 ordinary shares of 1 pence each ('Ordinary Shares') with voting rights. The Company does not hold any Ordinary Shares in treasury. Therefore, the total number of voting rights in the Company is 102,705,557 and this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

 

**ENDS**

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.

 

For further information, please visit www.sigmaroc.com or contact:

 

SigmaRoc plc +44(0)207 129 7828

Max Vermorken

 

Strand Hanson Limited (Nominated and Financial Adviser) +44(0)207 409 3494

James Spinney

James Dance

 

Zeus Capital Limited (Joint Broker) +44(0)203 829 5000

Rob Collins

Alex Wood

 

Berenberg (Joint Broker) +44(0)203 207 7800

Ben Wright

Laure Fine

 

Temple Bar Advisory (Public Relations Advisor) +44(0)207 002 1080

Ed Orlebar

Tom Allison

Alycia MacAskill

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDDGGDURBGBGRD
Date   Source Headline
29th Dec 20207:00 amRNSHolding(s) in Company
22nd Dec 20207:00 amRNSNew expanded £125 million Credit Facility
15th Dec 20204:20 pmRNSHolding(s) in Company
15th Dec 202010:00 amRNSHolding(s) in Company
9th Dec 20203:25 pmRNSResults of Placing
9th Dec 20207:01 amRNSProposed Placing
9th Dec 20207:00 amRNSTrading update
22nd Sep 20207:00 amRNSAcquisition of leading quarrying group GDH
17th Sep 20205:00 pmRNSHolding(s) in Company
8th Sep 20207:00 amRNSInvestor Presentation
7th Sep 20207:00 amRNSInterim Results
3rd Sep 202011:30 amRNS2020 interim results: investor & analyst call
1st Sep 20207:00 amRNSAcquisition of leading quarrying group GDH
10th Aug 20206:00 pmRNSHolding(s) in Company
6th Aug 20208:30 amRNSHolding(s) in Company
4th Aug 202011:36 amRNSHolding(s) in Company
31st Jul 20207:00 amRNSDirector and PDMR Dealings
30th Jul 20207:00 amRNSTrading update
3rd Jul 20208:05 amRNSCDH agrees roadworks co-funding with Walloon Govt
9th Jun 20207:00 amRNSTrading Update
3rd Jun 202011:30 amRNSDirector and PDMR Dealings
18th May 20202:45 pmRNSResults of AGM
20th Apr 20207:01 amRNSBoard appointments
20th Apr 20207:00 amRNSAnnual results for year ended 31 December 2019
14th Apr 20207:00 amRNSHolding(s) in Company
9th Apr 202010:00 amRNSHolding(s) in Company
9th Apr 20209:15 amRNSAppointment of joint broker & FY2019 results call
6th Apr 20207:00 amRNSOperational Update
2nd Apr 202010:00 amRNSHolding(s) in Company
27th Mar 202012:05 pmRNSHolding(s) in Company
27th Mar 202012:00 pmRNSHolding(s) in Company
25th Mar 20207:00 amRNS2019 Results and Coronavirus Update
3rd Mar 20209:30 amRNSDirector and PDMR Dealings
2nd Jan 202010:38 amRNSDirector and PDMR Dealings
31st Dec 20199:16 amRNSGrant of Options and PDMR Dealing
19th Dec 20197:00 amRNSCredit Facility and Advisory Board
24th Oct 201911:24 amRNSHolding(s) in Company
24th Oct 201911:21 amRNSHolding(s) in Company
24th Oct 20199:05 amRNSHolding(s) in Company
23rd Oct 20195:00 pmRNSHolding(s) in Company
18th Oct 20195:10 pmRNSHolding(s) in Company
17th Oct 20195:48 pmRNSHolding(s) in Company
17th Oct 20194:10 pmRNSHolding(s) in Company
16th Oct 20192:21 pmRNSPDMR Dealings
15th Oct 20195:45 pmRNSSuccessful Completion of Placing
15th Oct 20191:52 pmRNSProposed Acquisition and Proposed Placing
10th Oct 20192:00 pmRNS£5.5m cash disposal of non-core land
30th Sep 20197:00 amRNSHalf-year Report
27th Sep 201911:15 amRNSResult of GM
11th Sep 20197:00 amRNSAcquisition, proposed board appointment & GM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.